CD8A and neoplasm: Based on the above data and our previous report showing that CTX/LNIL immunomodulation promotes CD8+ T cell tumor infiltration [20], we assessed whether CTX/LNIL and/or CRT could favorably alter the intratumoral lymphoid compartment using multi-color immunofluorescence and flow cytometry (Figs. 4 and 5).